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Introduction: In Thailand TB and MDR-TB treatment was found in 
all levels of the unit of health service system, but the failed 
treatment especially for MDRTB was found 8.2% in the lower part of 
northeastern Thailand. In the complex situation, only the medical 
care cannot eradicate MDR-TB. This study was aim to explain the 
failure treatment of patient with MDR-TB over 3 generations within 
1household. Method: This qualitative method collected data by in-
depth in the province located at northeast Thailand; 5 patients and 
failure treatment of MDR-TB were investigated. The data was 
analyzed using content analysis. Result: One grandmother, 78 years 
old, have had twice received treatments and still alive. The mother 
failed treatment and died from MDR-TB at 54 years old aggravated 
by noncompliance to drug treatment. The father defaulted treatment 
due to alcohol consumption, and the second treatment was cured but 
the subject died at 61 years old. The son and daughter comprised 
default treatment caused from the household problem of low income, 
drug addiction, alcohol consumption and divorce. The elder brother 
did not return to treatment and his symptoms worsened. However, 
the younger sister, 21 years old, returned to treatment for 4 months. 
The supportive factors of failed treatment that led patients to cease 
taking drugs more than 2 months and deny continuing treatment 
included low income, household problems and drug addiction. 
Recommendation: Only the medication could not cure or achieve 
successful treatment, but socio-economic factors such as the 
understanding of the patient’s context was crucial equally the same 
as the MDR-TB drug. This factor was effecting to compliance of 
MDR-TB patient care and treatment. 
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Introduction 
 
Multi-Drug Resistance Tuberculosis (MDRTB) is the major problem of 
Tuberculosis disease. Global report was found MDRTB 29,243 cases from 127 
countries; it was 7% of expectation case around 440,000 cases [1]. The survey of 
MDRTB in the year 2005-2006 was found the rate of MDRTB infection in 
MDRTB new case was 1.65%, where as in the TB patient who turn to be 
MDRTB was 34.54% [2]. 
The researches about the MDR-TB were found the factors influencing to the 
treatment outcome; the factor of patient’s health behaviors, drink alcohol during 
treatment, lacking of the nutrient and low body weight, socio-economic and 
mental status, poor, the standard of DOTS, and community participation and 
cooperation on DOT-PLUS [3,4,5,6]. The risk factors for treatment failure were 
presence of extensive drug resistant, underlying comorbidity and higher level of 
albumin was inversely associated with the treatment failure [7]. The study about 
an intervention in France, carried out by NRC staff (National Reference Centre), 
was found the median duration of treatment was shorter than planed (12 
months), favorable outcome treatment was 70% [8]. The study in resources 
limited setting of 5 countries, the project was approved by the Green Light 
Committee (GLC) for access to quality assured second-line drugs provided at 
reduce price. It was found treatment successful in 70%, divided in new patient 
77% and previously treated patient 69% [9]. In conclusion of the research issues 
on MDR-TB, the crucial factors related to the successful treatment of MDR-TB 
were the cooperation from various parts from in the national to local level, 
especially for the community cooperation and participation to care of MDR-TB 
patient. As in Thai’s community society the various parts in the community for 
care of the patient is namely as social capital. In Thai’s society, social capital has 
been the most powerful for solving problem complicatedly in the community such 
as people living with HIV/AIDS in the Thai’s community [10].  
The report of MDRTB treatment patients, 121 cases, from the Office of 
Disease Prevention and Control region 7th Ubon Ratchathani (ODPC 7th) 
between 2006-2011 was cure and complete treatment 46.2%. The problem added 
were many systems of data record, lack of patient compliance to treatment, and 
the un-readiness of the public health personnel in the community to care of 
MDRTB patient. These reasons were causes of treatment failure and distribution 
of the disease. And we found the Failure Treatment of MDR-TB in Three 
Generations in one household in ODPC 7th region. This situation was led to the 
question what the causes of the MDRTB treatment failure within one household 
and the distribution of the disease within the household. The objective of this 
study was to explain the failure treatment of MDR-TB patient in three 
generations within one household 
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Conceptual framework  
 
This study was focusing on the phenomena of MDRTB treatment failure in 
the lower part of northeast Thailand. The concept of social capital, an access to 
health care service of the MDRTB patient, and health belief model was applied 
for the conceptual framework of this study 
 
 
Figure1:  Conceptual Framework 
 
 
Methodology 
 
  This study was qualitative research. The study area was the province 
located in the lower part of northeast of Thailand that was found the MDRTB 
patient in tree generation within one household and their all were failure 
treatment or/and stop MDRTB drug more than 2 months. Target was one 
household with 5 people who diagnosis was MDRTB patient with the history of 
failure treatment and stop MDRTB drug more than 2 months.  
The data collection tools was the semi-structure interview guide about how 
the patient access to treatment, self-care, perception of the risk from MDRTB 
disease, supportive from the public health clinic, community and neighborhood, 
family and the lineage about the self care and how to compliance to MDRTB 
drug, and the problem and obstacle from MDRTB care and treatment. The 
observation guides about the family relation the environment of the patient 
house and relationship to the neighborhood. The in-depth interview, participation 
and non-participation observation, and the documentary of patient history form 
were used for data collection method. Content analysis was used for data 
analysis. 
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Research Result  
 
4.1 Household information:  
5 people in the household were failure treatment and stop MDRTB drug more 
than 2 month, comprise of the grand mom, parent one daughter and one son. 
The house is located in Amphur Muang in the province of northeast Thailand.  
The parent, mother was the food seller in the school and the father was an 
employee, was pass away because of MDRTB treatment failure. Grand mom was 
cure from Tuberculosis with the history of twice time of TB treatment, due to 
failure of treatment one time. After the parent pass away the son and daughter 
was infected MDRTB and sickness with severe symptom from the disease. The 
son was married with Laos people after he sickness and work as the truck driver 
to sent the goods to another provinces. During treatment MDRTB not more than 
6 months he stop taking drug due to the trouble to his work and he was a drug 
addicted at the same time and he got divorce with his wife. For his younger 
sister, she is a housewife. She was not concern to the disease until the symptoms 
was worse. The crucial problem of this family was the economic, non security 
career of employee and drug and alcohol addicted. All factors were effects to the 
disease and health status.  
 
4.2 History of MDRTB disease of the patient: 
 Case1; grand mom, 78 years old after cured from TB treatment twice times 
she was moved to another house that 200 meters from that one and still alive.  
Case 2; mother, 54 years old, pass away on 2005. The major cause of failure 
treatment of MDRTB was discouraged with the treatment. She moves to another 
house in order to hide herself from the public personnel and treatment. After she 
dies her daughter was found big amount of the pill under her bed. 
Case 3; father, 61 years old, pass away on 2013. He was failure treatment and  
re-treatment of MDRTB twice times. This case found the problem of the delay 
detection of MDRTB plus with he was alcohol addicted. This was the major 
cause of treatment failure. However, this case was cure treatment in the twice 
times of treatment. At the third time of recurrent MADRTB he did not access to 
treatment because he was a dunker and deny to treatment and he dies finally. 
Case 4; the son, 24 years old, he was treatment of MDRTB twice time. 
Because of his career of the truck driver and he was a drug addicted. It made 
him got worse the most with drug resistance. The disease was getting worse and 
resists more drugs that were Ofloxacine and Ethionamidethus, normally was 
resistance to INH and Rifampicine. The doctor was order injection drug continue 
for 6 months. The patient was discouraged and wants to earn the money from 
truck driver, so he discontinuous treatment by himself. 
Case 5; the daughter, 21 years old, she was treatment twice times. The first 
time of treatment was taking drug for 1 month and she stop taking drug. Two 
year after stop treatment her symptoms was getting worse the most with cough 
and suffocate, then she turned to treatment MDRTB.   
Causes of TB distribution was originate from the grand mom who infected 
Tuberculosis then distribute to her daughter who was the mother and the major 
cause of MDRTB distribute to all family’s members. Three of 5 MDRTB patients 
in this household were dying. The cause of dying was stop treatment 
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simultaneous with they were lacking of self health care, drug and alcohol 
addicted, economic problem, divorces, lacking of willpower and discouraged to 
treatment. 
 
4.3 Causes of treatment failure, non-adherence, and 
MDRTB distribution in the household 
 The cause of MDRTB distribution in family, non adherence to drug, and 
treatment failure from the study household was the problem of the family in 
term of economic, divorces that was led to the obstacle of access to care and 
treatment of MDRTB and led to physical and mental state, and daily life of the 
patient. The result of these factors was the patient stop taking drug and failure 
treatment finally as a detail in the Figure2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure2: Causes Model of default and failure treatment of MDRTB treatment in case of the patient with complexity 
problem 
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Discussion  
 
 This study was shown the crucial causes of non adherence to drug and failure 
treatment of MDRTB in three generations within one household were the 
problem’s family in term of economic, drug addicted, and lacking of DOTs in the 
family. The free of charge for MDRTB treatment and the improvement of quality 
of Lab investigation system was unsuccessful for MDRTB treatment especially 
for the patient who has had the complex problems as in this study. The 
comprehensive care and social capital support to the mental state, willpower, and 
living with full meaning of the patient as well as the stability of family economic 
during on treatment of MDRTB were the crucial factors that influence to the 
successful outcomes treatment.  
This study was found that for the patient who has had complex problems 
should be concern to the importance components of the problem and find out the 
way of hoe to solving the problem the same as the medical treatment.  Beside for 
the medical treatment it should be strengthen to the DOTs with care giver in the 
MDRTB clinic, in the community, and in the family by the cooperation and 
participation of the community.  
 
 
Recommendation 
 
  (1) It should be the model of multidisciplinary team with the community 
participation to care and treatment of MDRTB patient, especially for the patient 
with complex problem. The method of DOTs and socio-economic support was 
importance the most for care of MDRTB patient. 
 (2) It should be encourage the community to concern about the risk and the 
health status effecting to the people in community and support the new 
technique and multidisciplinary team to solving problem in the community. 
 (3) It should be building the local policy to setting up the multidisciplinary 
team by the community participation to prevention and control of MDRTB in 
the community. 
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